The occurrence of persistent neutrophilic leukocy­tosis above 50,000 cells/μL for reasons other than leukemia is defined as leukemoid reaction. Chronic myelogenous leukemia (CML) and chronic neutro­philic leukemia (CNL) should be excluded, and un­derlying diseases or causes should be examined, in differential diagnosis. The most commonly ob­served causes of leukemoid reactions are severe infections, intoxications, malignancies, severe hem­orrhage, or acute hemolysis [1]. J Clin Exp Invest 2013; 4 (2): 258-259.
Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Gia- marellou H. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med 2006;17:394-398.
Olipitz W, Strunk D, Beham-Schmid C, Sill H. Neutro- philic leukemoid reaction as the presenting feature of de novo and therapy-related acute leukemias. Acta Haematol 2004;111 :233-234.
Kaung DT. Leukemoid reaction in acute lymphoblastic leukemia: a response to chemotherapy. J Iowa Med Soc 1973;63:114-117.
Liu CZ, Persad R, Inghirami G, et al. Transient atypical monocytosis mimic acute myelomonocytic leukemia in post-chemotherapy patients receiving G-CSF: re- port of two cases. Clin Lab Haematol 2004;26:359- 362.
Schmid C, Frisch B, Beham A, et al. Comparison of bone marrow histology in early chronic granulocytic leukemia and in leukemoid reaction. Eur J Haematol 1990;44:154-158.
Florena AM, Franco V, Iannitto E, Salvato M. [Immuno- phenotyping of early-phase chronic myeloid leukemia and leukemoid reaction]. Pathologica 1994;86:384- 391.
Sun CY, Lin HC, Chen YC, et al. Leukemoid reaction after methotrexate-induced pancytopenia in a patient undergoing continuous ambulatory peritoneal dialy- sis. Chang Gung Med J 2006;29:513-517.
Mori H, Shibuya T, Osada T, et al. Response to che- motherapy in a case of gastric adenocarcinoma pro- ducing granulocyte colony-stimulating factor. Med Sci Monit 2010;16:CS119-123.
Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon
The occurrence of persistent neutrophilic leukocy­tosis above 50,000 cells/μL for reasons other than leukemia is defined as leukemoid reaction. Chronic myelogenous leukemia (CML) and chronic neutro­philic leukemia (CNL) should be excluded, and un­derlying diseases or causes should be examined, in differential diagnosis. The most commonly ob­served causes of leukemoid reactions are severe infections, intoxications, malignancies, severe hem­orrhage, or acute hemolysis [1].
Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Gia- marellou H. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med 2006;17:394-398.
Olipitz W, Strunk D, Beham-Schmid C, Sill H. Neutro- philic leukemoid reaction as the presenting feature of de novo and therapy-related acute leukemias. Acta Haematol 2004;111 :233-234.
Kaung DT. Leukemoid reaction in acute lymphoblastic leukemia: a response to chemotherapy. J Iowa Med Soc 1973;63:114-117.
Liu CZ, Persad R, Inghirami G, et al. Transient atypical monocytosis mimic acute myelomonocytic leukemia in post-chemotherapy patients receiving G-CSF: re- port of two cases. Clin Lab Haematol 2004;26:359- 362.
Schmid C, Frisch B, Beham A, et al. Comparison of bone marrow histology in early chronic granulocytic leukemia and in leukemoid reaction. Eur J Haematol 1990;44:154-158.
Florena AM, Franco V, Iannitto E, Salvato M. [Immuno- phenotyping of early-phase chronic myeloid leukemia and leukemoid reaction]. Pathologica 1994;86:384- 391.
Sun CY, Lin HC, Chen YC, et al. Leukemoid reaction after methotrexate-induced pancytopenia in a patient undergoing continuous ambulatory peritoneal dialy- sis. Chang Gung Med J 2006;29:513-517.
Mori H, Shibuya T, Osada T, et al. Response to che- motherapy in a case of gastric adenocarcinoma pro- ducing granulocyte colony-stimulating factor. Med Sci Monit 2010;16:CS119-123.
Yokuş, O., Albayrak, M., Albayrak, A., Gedik, H. (2013). Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon. Journal of Clinical and Experimental Investigations, 4(2). https://doi.org/10.5799/ahinjs.01.2013.02.0280
AMA
Yokuş O, Albayrak M, Albayrak A, Gedik H. Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon. J Clin Exp Invest. Haziran 2013;4(2). doi:10.5799/ahinjs.01.2013.02.0280
Chicago
Yokuş, Osman, Murat Albayrak, Aynur Albayrak, ve Habip Gedik. “Akut Lenfoblastik lösemili Hastada Ikinci Kemoterapi Sonrası gelişen lökomoid Reaksiyon”. Journal of Clinical and Experimental Investigations 4, sy. 2 (Haziran 2013). https://doi.org/10.5799/ahinjs.01.2013.02.0280.
EndNote
Yokuş O, Albayrak M, Albayrak A, Gedik H (01 Haziran 2013) Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon. Journal of Clinical and Experimental Investigations 4 2
IEEE
O. Yokuş, M. Albayrak, A. Albayrak, ve H. Gedik, “Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon”, J Clin Exp Invest, c. 4, sy. 2, 2013, doi: 10.5799/ahinjs.01.2013.02.0280.
ISNAD
Yokuş, Osman vd. “Akut Lenfoblastik lösemili Hastada Ikinci Kemoterapi Sonrası gelişen lökomoid Reaksiyon”. Journal of Clinical and Experimental Investigations 4/2 (Haziran 2013). https://doi.org/10.5799/ahinjs.01.2013.02.0280.
JAMA
Yokuş O, Albayrak M, Albayrak A, Gedik H. Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon. J Clin Exp Invest. 2013;4. doi:10.5799/ahinjs.01.2013.02.0280.
MLA
Yokuş, Osman vd. “Akut Lenfoblastik lösemili Hastada Ikinci Kemoterapi Sonrası gelişen lökomoid Reaksiyon”. Journal of Clinical and Experimental Investigations, c. 4, sy. 2, 2013, doi:10.5799/ahinjs.01.2013.02.0280.
Vancouver
Yokuş O, Albayrak M, Albayrak A, Gedik H. Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon. J Clin Exp Invest. 2013;4(2).